Literature DB >> 6766084

Clinical delivery system for intraperitoneal hyperthermic chemotherapy.

J S Spratt, R A Adcock, M Muskovin, W Sherrill, J McKeown.   

Abstract

A 35-year-old man was treated for pseudomyxoma peritonei by surgery and by thermal infusion and chemotherapy with a machine designed specifically for the treatment of cancers of serosal surfaces. After extensive abdominal resection and closure, the patient's peritoneal cavity was instilled with 2.5 liters of 5% lactated Ringer's solution. He was then attached to hyperthermic perfusion system which elevated the i.p. temperature by warming (to 42 degrees) and recirculating the effusion solution. When the 42 degrees i.p. temperature was attained (after 1.5 hr), chemotherapy was added to the recirculating effusion. A second procedure followed 8 days later. The patient's postoperative course was uneventful except for minor pulmonary atelectasis with bacteremia. Hyperthermic perfusion was tolerated well and was evaluated as safe for intracavitary cancer treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6766084

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  100 in total

1.  Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer.

Authors:  S Fujimoto; R D Shrestha; M Kokubun; K Kobayashi; S Kiuchi; C Konno; M Ohta; M Takahashi; Y Kitsukawa; M Mizutani
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

2.  Intraperitoneal chemotherapy and its evolving role in management of gastric cancer with peritoneal metastases.

Authors:  Emel Canbay; Yutaka Yonemura; Bjorn Brucher; Seung Hyuk Baik; Paul H Sugarbaker
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

Review 3.  Cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy in patients with peritoneal carcinomatosis of colorectal origin.

Authors:  César P Ramírez Plaza; Manuel A Cobo Dols; Alberto Gómez Portilla; Agustín de la Fuente Perucho
Journal:  Clin Transl Oncol       Date:  2005-11       Impact factor: 3.405

Review 4.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 5.  Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.

Authors:  Ramez N Eskander; James Cripe; Robert E Bristow
Journal:  Curr Treat Options Oncol       Date:  2014-03

Review 6.  Surgical treatment of peritoneal carcinomatosis: current treatment modalities.

Authors:  Yakup Kulu; Beat Müller-Stich; Markus W Büchler; Alexis Ulrich
Journal:  Langenbecks Arch Surg       Date:  2013-11-19       Impact factor: 3.445

7.  Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer.

Authors:  Claudio Zanon; Renzo Clara; Isabella Chiappino; Massimiliano Bortolini; Silvia Cornaglia; Paolo Simone; Francesco Bruno; Leonarda De Riu; Mario Airoldi; Fulvia Pedani
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

8.  Hyperthermia in the treatment of cancer.

Authors:  N M Bleehen
Journal:  Br J Cancer Suppl       Date:  1982-03

Review 9.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence.

Authors:  Wim P Ceelen; Michael F Flessner
Journal:  Nat Rev Clin Oncol       Date:  2009-12-15       Impact factor: 66.675

10.  [Effect of local moderate hyperthermia in combination with N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) and 5-fluoro-(tetrahydro-2-furyl)uracil (ftorafur) on induced autochthonous colonic cancers in the rat. 3: Polychemotherapy in combination with hyperthermia].

Authors:  E Biwer; M Lorenz; M Habs; D Schmähl
Journal:  Langenbecks Arch Chir       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.